Invention Grant
- Patent Title: Prevention and treatment of thromboembolic disorders
- Patent Title (中): 预防和治疗血栓栓塞性疾病
-
Application No.: US11883218Application Date: 2006-01-19
-
Publication No.: US09539218B2Publication Date: 2017-01-10
- Inventor: Frank Misselwitz , Dagmar Kubitza , Son-Mi Park , Klaus Wehling
- Applicant: Frank Misselwitz , Dagmar Kubitza , Son-Mi Park , Klaus Wehling
- Applicant Address: DE Monheim am Rhein
- Assignee: BAYER INTELLECTUAL PROPERTY GMBH
- Current Assignee: BAYER INTELLECTUAL PROPERTY GMBH
- Current Assignee Address: DE Monheim am Rhein
- Agency: Buchanan Ingersoll & Rooney PC
- Priority: EP05001893 20050131
- International Application: PCT/EP2006/000431 WO 20060119
- International Announcement: WO2006/079474 WO 20060803
- Main IPC: A61K31/00
- IPC: A61K31/00 ; A61K31/5377
Abstract:
The present invention relates to the field of blood coagulation, more specifically it relates to a method of treating a thromboembolic disorder by administering once daily a direct factor Xa inhibitor in oral dosage form to a patient in need thereof, wherein the factor Xa inhibitor has a plasma concentration half life indicative of a bid or tid administration interval, e.g. of 10 hours or less.
Public/Granted literature
- US20090004265A1 Prevention and Treatment of Thromboembolic Disorders Public/Granted day:2009-01-01
Information query
